patients on Alnylam commercial therapies worldwide
U.S. lives with confirmed access to one of our four products
markets where patients have received access to Alnylam therapies
Alnylam Assist® offers you a number of personalized services throughout your treatment with an Alnylam product.
Alnylam Act® provides no-charge, independent genetic testing and counseling to individuals in the U.S. and Canada who may have hATTR amyloidosis, acute hepatic porphyria, or primary hyperoxaluria type 1.